129 Xe interacts with biological media to exhibit chemical shifts exceeding 200 ppm that report on physiology and pathology. Extracting this functional information requires shifts to be measured precisely. Historically, shifts have been reported relative to the gas-phase resonance originating from pulmonary airspaces. However, this frequency is not fixed-it is affected by bulk magnetic susceptibility, as well as Xe-N 2 , Xe-Xe, and Xe-O 2 interactions. In this study, we addressed this by introducing a robust method to determine the 0 ppm 129 Xe reference from in vivo data. Methods: Respiratory-gated hyperpolarized 129 Xe spectra from the gas-and dissolved-phases were acquired in four mice at 2T from multiple axial slices within the thoracic cavity. Complex spectra were then fitted in the time domain to identify peaks. Results: Gas-phase Xe resonance exhibits a stable frequency across all mice. Therefore, it can provide a reliable in vivo reference frequency by which to characterize other spectroscopic shifts.
INTRODUCTION
Hyperpolarized (HP) 129 Xe MR spectroscopy is emerging as a powerful in vivo probe of tissue composition, physiology, and pathology (1) . This is enabled by three unique properties. First, 129 Xe is metabolically inert but readily interacts with liquids, biological membranes, proteins, and lipid bilayers within living systems (2) . Upon inhalation, it freely diffuses across the pulmonary-capillary barrier and dissolves in blood to be transported to distal regions such as the heart, brain, and kidneys (3) . Second, 129 Xe exhibits a wide range of chemical shifts-larger than any other biologically relevant NMR-sensitive nucleus. Furthermore, these shifts are sensitive to physiological variations, local tissue microenvironments, and xenon chemical exchange between them (2,4). Finally, because the 129 Xe nuclear spin polarization can be enhanced by hyperpolarization (5), its frequency shifts can be detected from modest concentrations in distal tissues. 129 Xe chemical shifts have been studied extensively in vitro to examine the interaction of 129 Xe with cells and blood (4, (6) (7) (8) (9) (10) . With the advent of hyperpolarization, it has become possible to characterize shifts in mice (11) (12) (13) (14) (15) , rats (3, 8, 16, 17) , and humans (18) (19) (20) (21) . Across these species, four 129 Xe resonances have been reported within the thorax: airspaces (À5 to 10 ppm), aqueous media (195-199 ppm) , red blood cells (mouse, 199-200 ppm; rat, 210-213 ppm; human, 216-221 ppm), and adipose tissue (189-194 ppm) . Beyond the thoracic cavity, dissolved 129 Xe has also been imaged in the lung, kidney, and brain, where similar chemical shifts have been reported (3, (21) (22) (23) (24) .
In vivo, dissolved-phase 129 Xe resonances exhibit interesting variations in amplitude, frequency, and linewidth. For example, in mouse models of lung cancer, the 129 Xe resonance in adipose tissue diminishes in size, subtly broadens, and also shifts downfield (25) . Moreover, 129 Xe resonances in patients with idiopathic pulmonary fibrosis also undergo significant changes in amplitude, width, and frequency, which can be exploited to probe blood oxygenation at the alveolar-capillary level (20) . Therefore, as we seek to identify and characterize not only new 129 Xe resonances, but also the manner in which they shift with physiological or physical changes, we must develop a more accurate methodology.
Historically, 129 Xe chemical shifts have been reported by phasing the airspaces. This standard practice has several shortcomings. First, rapid 129 Xe exchange between compartments leads to broad, overlapping resonances, making it challenging to accurately isolate contributions from individual components. Second, the accurate measurement of the 129 Xe gasphase resonance, which is used as a reference frequency, is surprisingly challenging. By convention, this frequency should represent 129 Xe gas at zero pressure (2) . Naturally, such signal is unobservable, and therefore signals are acquired at positive pressure and corrected using the known Xe-Xe interaction shift of 0.548 6 0.004 ppm/amagat * (26) . For in vivo studies, collisions of 129 Xe with nitrogen and oxygen introduce additional shifts of 0.209 6 0.020 and 0.939 6 0.009 ppm/amagat (27) (28) (29) . However, perhaps the greatest difficulty for in vivo studies is that the gas-phase 129 Xe reference originates mostly from airspaces inside the body, which was recognized by Wagshul et al. (13) to be shifted by as much as À2 to À3 ppm from the true zero frequency by bulk magnetic susceptibility (BMS) effects. Given these confounding effects, previous reports of particular 129 Xe dissolved-phase chemical shifts have varied by as much as 2 to 3 ppm.
To minimize the variability in future reports of chemical shifts across different centers and between animals, we sought to introduce a robust methodology to identify 129 Xe resonances and their spectral parameters. We employed slice-selective spectroscopy to study the spatial variation of the gas-phase spectrum and implemented time domain curve-fitting to decompose the complex gas-phase signal into its alveolar and airway components. Using this tool, we established a consistent 0 ppm reference and used these methods to identify five consistent peaks in the 129 Xe dissolved-phase spectrum arising from the mouse thorax.
METHODS

Xe Polarization and MR Hardware
Natural abundance xenon gas (26% 129 Xe; Spectra Gases Inc., Alpha, New Jersey, USA) was polarized to approximately 20% using a commercial polarizer (Model 9800; Polarean Inc., Durham, North Carolina, USA). It was then dispensed in 150-mL volumes into a Tedlar bag (Jensen Inert Products, Coral Springs, Florida, USA), which was connected to an MR and HP gas-compatible constant volume ventilator (30) . Studies were conducted on a 2T preclinical magnet (Oxford Instruments, Oxford, UK) controlled by a GE EXCITE 12.0 console, and using a quadrature dual-tuned 129 H coil. During acquisition, warm air was circulated through the magnet bore to maintain normal body temperature, and the animal's rectal temperature, electrocardiogram, and airway pressure were monitored.
In Vivo 129 Xe Gas-Phase Spectroscopy
Before performing 129 Xe spectroscopy, a 1 H localizer scan was employed to accurately center the lungs of the mouse in the bore. Using this positioning reference, HP 129 Xe gas-phase spectra were acquired from a 2-cm slice encompassing the entire thoracic cavity, as well as from 1-cm slices positioned sequentially from the base of the lung (À9 mm from center) to the trachea (9 mm from center) in 1-mm increments. Spectra were acquired using the following parameters: slice-selective 90 flip angle by 1.2-ms, three-lobe sinc pulse [3.3 kHz bandwidth resulting in flip angle <1 to the dissolved-phase (31)]; TR ¼ 750 ms; TE ¼ 1.2 ms; 2048 points; receiver bandwidth ¼ 8.06 kHz; and number of excitations ¼ 21. Each free-induction decay (FID) was acquired over a single breath and gated to commence at full inspiration during the 200-ms breath-hold.
An identical study was conducted using HP 3 He as a control. Pure 3 He gas (Spectra Gases Inc.) was polarized to approximately 30% using a prototype polarizer (IGI.9600.He, MITI, Durham, North Carolina, USA) and delivered as described for the 129 Xe studies. Because 3 He is insoluble in tissues, any shifts detected in 3 He spectra can be attributed entirely to BMS effects.
In Vivo 129 Xe Dissolved-Phase Spectroscopy
By increasing the transmit/receive frequency to 194 ppm above the gas-phase frequency, dissolved-phase 129 Xe spectra were also acquired from the thoracic cavity. The acquisition parameters were identical to those of the gasphase studies, except that TR was progressively increased from 0.1 s to 8 s. This enabled studying how * An amagat is a practical unit of number density corresponding to 1 atm of ideal gas molecules at 0 C. Jameson et al. (26) expressed the 129 Xe chemical shift in xenon gas in terms of a chemical shielding constant, s ¼ À0.548 6 0.004 ppm/amagat. This can be related to the more conventional chemical shift of ppm/amagat by using the expression B eff ¼ (1 À s) B 0 . Thus, the negative shielding coefficient yields a positive xenon-induced chemical shift.
Accurate 129 the spectrum evolved as xenon entered tissues progressively distal from the alveolar-capillary interface.
Processing of Spectra
Complex spectra were processed in MATLAB using open-source software available for research use from www.civm.duhs.duke.edu/NmrSpectroscopy. The algorithm decomposes a FID into a series of additive Lorentzian components that are described by four parameters: amplitude (a n ), starting phase (f n ), resonant frequency f 0 À f n ð Þ , and linewidth (w n ):
a n e if n e 2pi f0Àfn ð Þ t e Àpwnt : [1] These parameters were fitted to minimize the least squares error of the complex data using a trust-regionreflective algorithm (32) . Additional components were included until the residual error between measured and fitted data became unpatterned. Because curve fitting was performed in the time domain, no line-broadening or zero-padding was needed. All spectral components were displayed in the frequency domain with their starting phases as acquired, as well as shifted to zero phase.
RESULTS
In Vitro 129 Xe Spectroscopy Figure 1a shows the change in resonant frequency of dynamic 129 Xe gas-phase spectra recorded from a tube containing a Xe-N 2 mixture transitioning from pure N 2 to pure 129 Xe, as HP 129 Xe constantly flowed through the tube. The resonant frequency recorded at 100%
129 Xe concentration-after correcting for the Xe-Xe shift of 0.548 6 0.004 ppm/amagat-served as the true 0 ppm reference frequency. Using this reference, the chemical shift of highly diluted 129 Xe in N 2 gas was measured to be 0.22 6 0.02 ppm, which is consistent with the Xe-N 2 shift of 0.209 6 0.020 ppm/amagat reported by Jameson et al. (28, 29) . Figure 1b additionally illustrates the effect of the Xe-O 2 shift in the high-pressure thermal phantom. Using the zero reference just described, its resonant frequency was measured at 5.77 6 0.02 ppm, which is within the error of the 5.3 6 1.4 ppm shift calculated using the known gas densities of 6.48 6 0.92 amagats of 129 Xe, and 1.84 6 0.92 amagats of O 2 . Thus, by subtracting 5.77 ppm from the measured frequency of this phantom, the 0 ppm reference was calculated on a scan-byscan basis. (This reference value is not affected by the uncertainty in this phantom's internal gas densities because true zero is derived from the flowing atmospheric phantom.) The 129 Xe frequency in the thermal phantom was measured approximately 2 hours prior to the mouse scans, and this time difference could potentially introduce an error in chemical shifts depending on the stability of the 2T field. However, we determined that field only drifted by À5.79 Hz/day or À0.24 ppm/ day, thus introducing a maximum error of 0.02 ppm that, though negligible relative to the statistical errors across the cohort (>0.1 ppm), was incorporated.
In Vivo 129 Xe Gas-Phase Spectroscopy Figure 2b illustrates the variation of the line shape of the in vivo gas-phase 129 Xe spectrum at different axial positions within the thoracic cavity. Spectra from the most inferior slices exhibited a dominant single resonance at approximately À2 ppm. As the slice was translated toward the center of the lung, a second distinct resonance grew at approximately 0 ppm. At the superiormost portions of lung, where the trachea dominates, the resonance exhibited a frequency exceeding 0 ppm.
These visually apparent features could be assessed more quantitatively by using curve fitting to decompose Xe spectra from both phantoms show that the high-density thermal phantom is shifted downfield from the low-density one.
the complex spectrum into individual resonances (Fig.  2c) . From the entire thoracic cavity (2-cm slice), two resonances were found: 0.3 6 0.5 ppm and À2.2 6 0.1 ppm. However, spectra from 1-cm slices at different axial locations in the lung (Fig. 2d) showed differences in the relative amplitudes and frequencies of the two peaks. At the center of the lung, two approximately equal-sized resonances were seen at À0.6 6 0.2 ppm and À2.2 6 0.1 ppm. In superior slices, the downfield resonance dominated in amplitude and increased in frequency, ultimately to 1.3 6 0.3 ppm in the trachea. In contrast, near the base of the lung, only the upfield resonance remained. Its frequency was consistently measured at À2.2 6 0.1 ppm across all mice and all spatial locations.
All measurements represent the mean 6 standard error across all mice.
In Vivo 129 Xe Dissolved-Phase Spectroscopy
Having a robust 0 ppm reference led us to more thoroughly investigate numerous dissolved-phase 129 Xe resonances in the thorax and accurately report their chemical shifts. These are illustrated in Figure 3 as a function of increasing 129 Xe replenishment times. Individual resonances were extracted by curve fitting as shown in Figure 3b , and their evolution with replenishment time is shown in Figure 3c . At the lowest TR of 100 ms, the 129 Xe distribution was confined to the gas- 
DISCUSSION
The positional dependence of the two gas-phase peaks within the thoracic cavity suggests that the À2.2 ppm peak arises from 129 Xe in alveolar airspaces and the variable downfield peak arises from 129 Xe in conducting airways. This À2.2 ppm shift for alveolar 129 Xe signal is consistent with an empirical estimate of À2.46 ppm that factors in the BMS shift for 129 Xe in a sphere and positive shifts caused by Xe-Xe and Xe-O 2 interactions. The susceptibility shift in an alveolus-modeled as a sphere-is given by x e /3 (13, 33) , where x e is external susceptibility of the lung parenchyma [estimated as pure water ¼ À9.06 ppm (34) ]. This leads to a suggested shift of À3.02 ppm. However, under our experimental conditions, the alveoli contained 80% xenon and 20% O 2 at approximately 0.9 amagats, which contributed an additional downfield shift of 0.39 þ 0.17 ¼ 0.56 ppm. Thus, adding the susceptibility shift and the shift from the gas mixture returned an empirical estimate of À3.02 þ 0.56 ¼ À2.46 ppm. Alveolar 129 Xe signal intensity and frequency have been reported previously to also be affected by inflation level (13, 35) . To investigate this effect, gas-phase 129 Xe spectra were acquired from the thoracic cavity (2-cm slice) at full inspiration and at three different times during exhalation. The alveolar resonance was extracted from these spectra and its frequency was correlated with its intensity, which served as a surrogate for inflation. As illustrated in Figure  4 , the frequency of this peak decreased linearly from full inspiration to lower inflation levels (r ¼ À0.99) and ultimately shifted by À0.09 ppm at end-expiration.
This change in alveolar 129 Xe frequency is smaller, but in the same direction as the À0.3 ppm shift between the two stages of the breathing cycle in the 3 He spectral frequency reported by Chen et al. in guinea pigs (35) . The larger shift shown by Chen et al. may be a function of species or tidal volume. Such inflation-dependent shifts in the gas-phase alveolar 129 Xe peak were also reported by Wagshul et al. (13) in free-breathing mice to be 0 to À0.4 ppm in one mouse, whereas no inflation effects were noted in another mouse suspected of shallow breathing. Despite modest differences in the magnitude of reported shifts, all three studies suggest the alveolar 129 Xe resonant frequency becomes more negative at endexpiration. That effect is attributable to the way in which lung inflation alters the volume-weighted average susceptibility of the gas and parenchymal tissue phases (33) .
Whereas the relatively stable alveolar 129 Xe resonant frequency can be explained by BMS effects arising from a spherical geometry, the airway resonance is somewhat more enigmatic. The variations in the airway peak frequency are also attributable to BMS effects but arise from a cylindrical geometry that depends on orientation. Such BMS shifts are expressed by
where u is the angle between the cylinder axis and B 0 direction and x i and x e represent the susceptibilities inside and outside it (33). We again assume x i ¼ 0 ppm, and x e ¼ À9.06 ppm and thus, depending on the orientation of an airway relative to B 0 , BMS shifts in cylinders range from 0 (parallel to B 0 ) to x e /2 (orthogonal). Thus, the line shape of the airway component of the gas-phase 129 Xe spectrum is likely derived from weighted contributions of airways at various orientations. In our sliceselective spectra, the base of the lung did not exhibit any detectable airway 129 Xe signal, which we attribute to this region containing acini that contribute little signal relative to alveolar 129 Xe. As the slice moves from lung base to apex, an increasingly dominant and higher-frequency airway resonance is observed, consistent with more airway contributions and progressive alignment of the larger airways with B 0 . Ultimately, the highest frequency airway peak was observed in the superior-most slice containing the trachea, which was roughly parallel to B 0 . However, its resonant frequency of 1.3 ppm cannot be explained within the framework of cylindrical BMS shifts, which for diamagnetic tissues predicts only shifts <¼0 ppm.
One additional mechanism that could shift the gasphase 129 Xe frequency would be provided by the bulk magnetic moment of hyperpolarized 129 Xe in airways. Such a shift should depend on both 129 Xe polarization and the geometry in which it is confined. These effects can be estimated by considering the additional magnetic field provided by the magnetization M in the trachea, which we consider as a cylinder aligned with B 0 . For this geometry, the total field is given by
where H is the applied magnetic field and M can be expressed as
where 129 Xe ½ is the density of 129 Xe atoms and P 129Xe is their polarization. Assuming [
129 Xe] ¼ 0.57 amagats and P 129Xe ¼ 20%, this creates a magnetization-related field DB ¼ À0.179 mG, which leads to an absolute frequency shift of À0.21 Hz. Although this is independent of the applied field strength, at 2T, it would correspond to a shift of only À0.009 ppm. Thus, bulk magnetization effects have a minor influence on gas-phase 129 Xe relative to the larger BMS-induced shifts. Moreover, if such magnetization effects played a major role, they would be 3 He exhibited similar location-specific frequency shifts and intensities as 129 Xe, confirming that these shifts are caused by bulk magnetic susceptibility effects.
Accurate 129 even more evident in the spectra of 3 He, which has a nearly three-fold larger magnetic moment and is isotopically pure.
To test this hypothesis, HP 3 He spectra were recorded from identical spatial positions within the mouse thorax (Fig. 5b) . In the absence of an accurate 0-ppm reference 3 He frequency, these spectra were displayed by aligning the most upfield 3 He resonance with the constant À2.2 ppm alveolar peak in the 129 Xe spectrum. 3 He spectra exhibited similar location-specific frequency shifts and intensities, with no discernible differences caused by its larger bulk magnetic moment. Furthermore, given its insolubility, this confirms that for both 129 Xe and 3 He, the shifts are caused exclusively by BMS effects, and not by chemical interaction or solvent shielding effects. Although the magnitude of the downfield 129 Xe frequency shift in major airways is unexpectedly large, the range of shifts found here agree with previous reports of in vivo 129 Xe spectra in mice (13) , in vivo 3 He spectra in guinea pigs (35) , ex vivo 1 H spectra in rat lungs (36) , and in vitro 23 Na spectra in cylindrical phantoms aligned at different orientations relative to B 0 (34) .
Although we used a thermal phantom scan to calculate the frequency reference for each 129 Xe study, our study clearly illustrates that the alveolar 129 Xe peak is reproducibly found within mice at À2.2 ppm and is relatively insensitive to inflation. Thus, in the absence of a phantom measurement, this robust alveolar gas peak can serve as a useful in vivo reference frequency. However, to use this signal, the spectrum should be carefully decomposed into separate alveolar and airway components. We note that our study did benefit from the highly homogeneous magnetic field over the approximately 2-cm extent of the mouse lung and must be validated for other species.
In addition to evaluating gas-phase frequency shifts, Lorentzian linewidths were also measured in the trachea and lung compartments. For reference, the linewidth over the 10-cm thermal phantom was 6 Hz. However, over 1-cm slices within the lung, the linewidths of both the alveolar and airway peaks were 50 6 7 Hz. This width implies a lower limit for T2* of 7 6 1 ms, which is shorter than that observed in guinea pig lungs (37) and human lungs (38) . This may be attributable to a denser airway and tissue architecture in the mouse lung. The estimated T2* in the trachea slice was somewhat longer at 15 6 5 ms. These relatively short T2* values in the mouse point to the advantages of imaging with radial sampling (39) .
The refined precision of the 0 ppm reference, combined with curve fitting of complex FIDs, has enabled us to more accurately identify and characterize the dissolved-phase 129 Xe resonances in the mouse thorax. Based on their signal dynamics, and the limited available literature, we can postulate the origins of these peaks. We suggest that the 198.4 ppm peak originates from blood (13, 40) , and the 195.5 and 193.9 ppm peaks from aqueous media (pulmonary-capillary barrier tissue, plasma, and possibly the myocardium). The remaining upfield peaks at <192 ppm, which only appear at long 129 Xe replenishment times, arise from the slowly perfused and distal epicardial fat (3) . With the exception of the two fat peaks, which could not be distinctly separated across the cohort, all the other peaks exhibited distinct frequencies (P < 0.01 for all pairwise comparisons using the Tukey-Kramer test).
CONCLUSION
We have characterized the variability of the gas-phase 129 Xe frequency in mice using slice-selective spectroscopy and decomposition of the complex FID to establish a robust method for setting an accurate 0 ppm reference using in vivo data. This framework also enabled five dissolved-phase resonances to be identified and their spectral parameters to be measured accurately. Our decomposition technique and accurate referencing methodology should facilitate standardized comparison across sites and aid in advancing the use of 129 Xe spectroscopy to detect pathology.
